Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
China
Biotech
California biotech Connects with Simcere in $141M licensing pact
Simcere is paying Connect Biopharma $21M upfront and offering up to $120M biobucks to develop and commercialize Connect’s mAb in Greater China.
Gabrielle Masson
Nov 21, 2023 11:07am
Fosun, Treehill join forces to invest in drugs angling for US
Nov 20, 2023 6:30am
Akeso's bispecific notches ph. 3 victory against gastric cancer
Nov 7, 2023 10:50am
Senti, Celest take cell therapy to China in $156M deal
Nov 7, 2023 10:15am
Resolian acquires China-based bioanalytical CRO Denali Medpharma
Nov 2, 2023 9:00am
Exelixis dips into the AI game, LIB cashes in on PCSK9
Sep 12, 2023 11:00am
